Yang et al. have shown that S100 calcium-binding protein P (S100P) and hyaluronoglucosaminidase 2 (HYAL2) may serve as biomarkers for diagnosing early-stage breast cancer, using the HumanMethylation27 BeadChip[127]. This evidence concerns the gene HYAL2 and breast cancer.